Matches in SemOpenAlex for { <https://semopenalex.org/work/W1691276340> ?p ?o ?g. }
- W1691276340 endingPage "1530" @default.
- W1691276340 startingPage "1517" @default.
- W1691276340 abstract "Introduction: Metastatic melanoma continues to present a significant therapeutic challenge, with an incidence rate rising faster than that of any other cancer. The last 5 years have seen a revolution in the development of new treatments for advanced melanoma, with oncogene targeted agents and checkpoint inhibitor immunotherapies providing the first convincing evidence of a positive shift in overall survival. The role of oncolytic virotherapy in this rapidly evolving field has long been the subject of debate. However, it is with the development of Talimogene Laheparepvec (T-Vec), an intratumourally administered, genetically modified clinical herpes simplex virus-1 strain that has shown positive results in Phase III testing, that the potential for the use of OV may be realised.Areas covered: This review will outline some of the recent advances in the treatment of advanced melanoma, with a detailed overview of evidence surrounding the development of T-Vec. A literature search was conducted using the databases ‘Medline’ and ‘Pubmed’, including a subsequent manual search of references to identify papers of further relevance.Expert opinion: As the pivotal OPTiM trial concludes, we outline some of the potential new directions for T-Vec and OV therapy and evaluate the ever-increasing role these novel agents are likely to play in the future landscape of cancer immunotherapy." @default.
- W1691276340 created "2016-06-24" @default.
- W1691276340 creator A5000089296 @default.
- W1691276340 creator A5013793491 @default.
- W1691276340 creator A5017101309 @default.
- W1691276340 creator A5067211956 @default.
- W1691276340 creator A5068910261 @default.
- W1691276340 creator A5069116024 @default.
- W1691276340 creator A5072284989 @default.
- W1691276340 creator A5072528382 @default.
- W1691276340 date "2015-09-07" @default.
- W1691276340 modified "2023-09-26" @default.
- W1691276340 title "Talimogene laherparepvec in the treatment of melanoma" @default.
- W1691276340 cites W1582164157 @default.
- W1691276340 cites W1607177619 @default.
- W1691276340 cites W1809627231 @default.
- W1691276340 cites W1833520300 @default.
- W1691276340 cites W1933198004 @default.
- W1691276340 cites W1964092676 @default.
- W1691276340 cites W1966502816 @default.
- W1691276340 cites W1968566356 @default.
- W1691276340 cites W1970039331 @default.
- W1691276340 cites W1971208896 @default.
- W1691276340 cites W1978558644 @default.
- W1691276340 cites W1980477679 @default.
- W1691276340 cites W1991148746 @default.
- W1691276340 cites W1998342624 @default.
- W1691276340 cites W1998933123 @default.
- W1691276340 cites W1999515277 @default.
- W1691276340 cites W2011586685 @default.
- W1691276340 cites W2019410232 @default.
- W1691276340 cites W2020849247 @default.
- W1691276340 cites W2038914273 @default.
- W1691276340 cites W2039123767 @default.
- W1691276340 cites W2039263693 @default.
- W1691276340 cites W2057382033 @default.
- W1691276340 cites W2058531798 @default.
- W1691276340 cites W2060816835 @default.
- W1691276340 cites W2063512646 @default.
- W1691276340 cites W2070707240 @default.
- W1691276340 cites W2078197336 @default.
- W1691276340 cites W2082150850 @default.
- W1691276340 cites W2086591619 @default.
- W1691276340 cites W2092997044 @default.
- W1691276340 cites W2095138364 @default.
- W1691276340 cites W2097000480 @default.
- W1691276340 cites W2097995306 @default.
- W1691276340 cites W2099289479 @default.
- W1691276340 cites W2099648846 @default.
- W1691276340 cites W2101653483 @default.
- W1691276340 cites W2102031533 @default.
- W1691276340 cites W2102557111 @default.
- W1691276340 cites W2104050479 @default.
- W1691276340 cites W2108216382 @default.
- W1691276340 cites W2109653150 @default.
- W1691276340 cites W2110410873 @default.
- W1691276340 cites W2112121482 @default.
- W1691276340 cites W2115918773 @default.
- W1691276340 cites W2122037714 @default.
- W1691276340 cites W2125980219 @default.
- W1691276340 cites W2127402954 @default.
- W1691276340 cites W2127839329 @default.
- W1691276340 cites W2128035403 @default.
- W1691276340 cites W2128542677 @default.
- W1691276340 cites W2128758225 @default.
- W1691276340 cites W2132191840 @default.
- W1691276340 cites W2133817804 @default.
- W1691276340 cites W2135686776 @default.
- W1691276340 cites W2136474966 @default.
- W1691276340 cites W2149223196 @default.
- W1691276340 cites W2152897456 @default.
- W1691276340 cites W2155777530 @default.
- W1691276340 cites W2156078931 @default.
- W1691276340 cites W2165320653 @default.
- W1691276340 cites W2165652424 @default.
- W1691276340 cites W2170739773 @default.
- W1691276340 cites W2171553929 @default.
- W1691276340 cites W2342031043 @default.
- W1691276340 cites W2766540508 @default.
- W1691276340 cites W2917837889 @default.
- W1691276340 cites W4211238487 @default.
- W1691276340 cites W4234329713 @default.
- W1691276340 cites W4244151305 @default.
- W1691276340 doi "https://doi.org/10.1517/14712598.2015.1084280" @default.
- W1691276340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26629575" @default.
- W1691276340 hasPublicationYear "2015" @default.
- W1691276340 type Work @default.
- W1691276340 sameAs 1691276340 @default.
- W1691276340 citedByCount "8" @default.
- W1691276340 countsByYear W16912763402016 @default.
- W1691276340 countsByYear W16912763402017 @default.
- W1691276340 countsByYear W16912763402019 @default.
- W1691276340 crossrefType "journal-article" @default.
- W1691276340 hasAuthorship W1691276340A5000089296 @default.
- W1691276340 hasAuthorship W1691276340A5013793491 @default.
- W1691276340 hasAuthorship W1691276340A5017101309 @default.
- W1691276340 hasAuthorship W1691276340A5067211956 @default.
- W1691276340 hasAuthorship W1691276340A5068910261 @default.